vs
Alexander & Baldwin, Inc.（ALEX）与Amarin Corp plc（AMRN）财务数据对比。点击上方公司名可切换其他公司
Alexander & Baldwin, Inc.的季度营收约是Amarin Corp plc的1.1倍（$51.0M vs $45.1M），Alexander & Baldwin, Inc.净利率更高（7.4% vs -23.3%，领先30.7%），Amarin Corp plc同比增速更快（7.0% vs -18.4%），过去两年Alexander & Baldwin, Inc.的营收复合增速更高（-8.7% vs -18.3%）
亚历山大-鲍德温公司是一家美国企业，曾是夏威夷领地时期五大财团之一，也是五大财团中最晚停止甘蔗种植的企业。目前公司主营房地产开发、土地运营以及建材与建筑业务，截至2020年，该公司是夏威夷最大的私人土地持有者之一，在当地拥有超2.8万英亩土地，运营着36处收益性物业。
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
ALEX vs AMRN — 直观对比
营收规模更大
ALEX
是对方的1.1倍
$45.1M
营收增速更快
AMRN
高出25.4%
-18.4%
净利率更高
ALEX
高出30.7%
-23.3%
两年增速更快
ALEX
近两年复合增速
-18.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $51.0M | $45.1M |
| 净利润 | $3.8M | $-10.5M |
| 毛利率 | — | — |
| 营业利润率 | 17.1% | 35.5% |
| 净利率 | 7.4% | -23.3% |
| 营收同比 | -18.4% | 7.0% |
| 净利润同比 | -69.7% | 33.0% |
| 每股收益（稀释后） | $0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALEXAMRN
| Q1 26 | — | $45.1M | ||
| Q4 25 | $51.0M | $49.2M | ||
| Q3 25 | $50.2M | $49.7M | ||
| Q2 25 | $51.7M | $72.7M | ||
| Q1 25 | $53.7M | $42.0M | ||
| Q4 24 | $62.4M | $62.3M | ||
| Q3 24 | $61.9M | $42.3M | ||
| Q2 24 | $51.0M | $67.5M |
净利润ALEXAMRN
| Q1 26 | — | $-10.5M | ||
| Q4 25 | $3.8M | $-1.2M | ||
| Q3 25 | $14.3M | $-7.7M | ||
| Q2 25 | $25.1M | $-14.1M | ||
| Q1 25 | $21.4M | $-15.7M | ||
| Q4 24 | $12.4M | $-48.6M | ||
| Q3 24 | $19.0M | $-25.1M | ||
| Q2 24 | $9.1M | $1.5M |
毛利率ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | — | 47.1% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 59.8% | ||
| Q4 24 | — | -15.4% | ||
| Q3 24 | — | 38.5% | ||
| Q2 24 | — | 63.4% |
营业利润率ALEXAMRN
| Q1 26 | — | 35.5% | ||
| Q4 25 | 17.1% | -12.9% | ||
| Q3 25 | 38.2% | -22.4% | ||
| Q2 25 | 54.4% | -22.0% | ||
| Q1 25 | 44.6% | -39.9% | ||
| Q4 24 | 28.3% | -84.3% | ||
| Q3 24 | 35.6% | -59.5% | ||
| Q2 24 | 31.8% | -0.8% |
净利率ALEXAMRN
| Q1 26 | — | -23.3% | ||
| Q4 25 | 7.4% | -2.5% | ||
| Q3 25 | 28.5% | -15.6% | ||
| Q2 25 | 48.6% | -19.4% | ||
| Q1 25 | 39.9% | -37.4% | ||
| Q4 24 | 19.9% | -78.0% | ||
| Q3 24 | 30.7% | -59.4% | ||
| Q2 24 | 17.8% | 2.3% |
每股收益（稀释后）ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | $0.05 | $0.00 | ||
| Q3 25 | $0.20 | $-0.02 | ||
| Q2 25 | $0.35 | $-0.03 | ||
| Q1 25 | $0.29 | $-0.04 | ||
| Q4 24 | $0.16 | $-0.12 | ||
| Q3 24 | $0.26 | $-0.06 | ||
| Q2 24 | $0.13 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.3M | $307.8M |
| 总债务越低越好 | $491.6M | — |
| 股东权益账面价值 | $987.2M | — |
| 总资产 | $1.7B | $645.8M |
| 负债/权益比越低杠杆越低 | 0.50× | — |
8季度趋势，按日历期对齐
现金及短期投资ALEXAMRN
| Q1 26 | — | $307.8M | ||
| Q4 25 | $11.3M | $302.6M | ||
| Q3 25 | $17.3M | $286.6M | ||
| Q2 25 | $8.6M | $298.7M | ||
| Q1 25 | $16.9M | $281.8M | ||
| Q4 24 | $33.4M | $294.2M | ||
| Q3 24 | $17.9M | $305.7M | ||
| Q2 24 | $29.5M | $306.7M |
总债务ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | $491.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $474.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | $987.2M | $459.3M | ||
| Q3 25 | $1.0B | $458.9M | ||
| Q2 25 | $1.0B | $464.9M | ||
| Q1 25 | $1.0B | $473.7M | ||
| Q4 24 | $1.0B | $486.2M | ||
| Q3 24 | $998.2M | $531.4M | ||
| Q2 24 | $1.0B | $551.9M |
总资产ALEXAMRN
| Q1 26 | — | $645.8M | ||
| Q4 25 | $1.7B | $670.8M | ||
| Q3 25 | $1.7B | $659.8M | ||
| Q2 25 | $1.6B | $670.1M | ||
| Q1 25 | $1.6B | $655.7M | ||
| Q4 24 | $1.7B | $685.3M | ||
| Q3 24 | $1.7B | $750.6M | ||
| Q2 24 | $1.6B | $799.9M |
负债/权益比ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | 0.50× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $79.5M | — |
| 自由现金流经营现金流 - 资本支出 | $27.3M | — |
| 自由现金流率自由现金流/营收 | 53.5% | — |
| 资本支出强度资本支出/营收 | 102.4% | — |
| 现金转化率经营现金流/净利润 | 21.06× | — |
| 过去12个月自由现金流最近4个季度 | $57.2M | — |
8季度趋势，按日历期对齐
经营现金流ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | $79.5M | $15.3M | ||
| Q3 25 | $24.5M | $-12.7M | ||
| Q2 25 | $16.5M | $16.6M | ||
| Q1 25 | $26.0M | $-12.5M | ||
| Q4 24 | $98.0M | $-13.3M | ||
| Q3 24 | $35.3M | $-2.4M | ||
| Q2 24 | $22.3M | $-2.7M |
自由现金流ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | $27.3M | — | ||
| Q3 25 | $-3.7M | — | ||
| Q2 25 | $11.8M | — | ||
| Q1 25 | $21.8M | — | ||
| Q4 24 | $77.0M | — | ||
| Q3 24 | $31.4M | — | ||
| Q2 24 | $18.0M | — |
自由现金流率ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | 53.5% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 40.6% | — | ||
| Q4 24 | 123.4% | — | ||
| Q3 24 | 50.8% | — | ||
| Q2 24 | 35.3% | — |
资本支出强度ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | 102.4% | — | ||
| Q3 25 | 56.1% | — | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 33.5% | — | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 8.4% | — |
现金转化率ALEXAMRN
| Q1 26 | — | — | ||
| Q4 25 | 21.06× | — | ||
| Q3 25 | 1.71× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | 7.88× | — | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | 2.45× | -1.81× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALEX
暂无分部数据
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
